Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02434133 · ClinicalTrials.gov registry record
Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 110
- Enrollment target
NCT02434133: Completed study, sponsored by University of Wisconsin, Madison.
NCT02434133 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02434133 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The investigators proposed study is the first of its kind. The investigators will measure measles, mumps, rubella, tetanus, diphtheria and pertussis antibodies in patients on the current IBD treatment modalities and compare the vaccine antibody concentrations and correlate them with time since immunization.
Primary Outcome
To compare tetanus, diphtheria, and pertussis antibody concentrations and seroprotection rates in patients with IBD treated with combination therapy to healthy individuals.
Interventions
- PROCEDURE Blood Draw/Data Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-12 |
What the finished NCT02434133 record still lists
NCT02434133 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw/Data Collection is the first listed.
NCT02434133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02434133 about?
NCT02434133 is a clinical study titled "Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients". The investigators proposed study is the first of its kind. The investigators will measure measles, mumps, rubella, tetanus, diphtheria and pertussis antibodies in patients on the current IBD treatment modalities and compare the vaccine antibody concentrations and correlate them with time since immun...
What is the current status of trial NCT02434133?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2015-04. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02434133?
The interventions under investigation include: Blood Draw/Data Collection (PROCEDURE).
Who is sponsoring clinical trial NCT02434133?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia